Actinium Pharmaceuticals, Inc.
(NYSE Amex Equities : ATNM)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
TSROTESARO, Inc.
0.10%73.7714.4%$580.73m
AMGNAmgen Inc.
0.69%193.391.2%$568.96m
GILDGilead Sciences, Inc.
2.03%66.900.9%$541.12m
CELGCelgene Corporation
2.33%69.791.2%$532.39m
BIIBBiogen Inc.
2.07%321.051.3%$366.83m
ILMNIllumina, Inc.
-0.54%324.713.5%$348.27m
REGNRegeneron Pharmaceuticals, Inc.
0.65%383.652.6%$274.89m
VRTXVertex Pharmaceuticals Incorporated
0.02%170.091.9%$226.51m
AAgilent Technologies, Inc.
-0.04%69.331.5%$225.41m
ALXNAlexion Pharmaceuticals, Inc.
3.38%113.132.0%$151.57m
INCYIncyte Corporation
0.54%66.612.5%$98.29m
EXASExact Sciences Corporation
0.32%68.5325.3%$93.69m
SRPTSarepta Therapeutics, Inc.
-1.15%118.1515.4%$89.73m
NKTRNektar Therapeutics
-0.30%36.405.5%$83.82m
EXELExelixis, Inc.
2.57%21.576.4%$82.26m

Company Profile

Actinium Pharmaceuticals, Inc. engages in the development of targeted therapies for patients with cancers lacking effective treatment options. The firm's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest in order to kill those cells. Its product pipeline includes Iomab-B, Actimab-A, and Actimab-M. The company was founded in 1993 and is headquartered in New York, NY.